Select Country

Select a country to view information on local trademark law


Countries
A-E  F-J  K-O  P-T  U-Z

Multinational Agreements
EUIPO  WIPO
AIPO/OAPI  ARIPO
Enter Client Voucher:  info

Get Listed

Promote your expertise to IP professionals worldwide.
read more

Subscribe to Free Newsletter

To keep updated on the latest amendments to international trademark laws click here

Articles

Print this page
Jan 24, 2012
Franck Soutoul, Inlex IP Expertise, France
Jean-Philippe Bresson, Inlex IP Expertise, France

New French exception to pharmaceutical IP rights


Franck Soutoul, Inlex IP Expertise, France, Jean-Philippe Bresson, Inlex IP Expertise, FranceA new French Law of December 29, 2011, has introduced article L. 5121-10-3 in the Public Health Code. Its provisions exclude generic drugs from trademarks and designs monopolies that relate to the appearance, shape or color of a reference pharmaceutical product.
French Law No. 2011-2012 relating to the ‘reinforcement of sanitary safety of medicines and health products’ of December 29, 2011 (published in the Official Journal on December 30, 2012) has introduced a new article L. 5121-10-3 in the Public Health Code which gives prevalence of Generics over trademarks and other IP right by providing the following:
“The owner of an intellectual property right protecting the appearance and the texture of oral pharmaceutical forms of a reference product […] cannot prohibit the oral pharmaceutical forms of  read more